“Stopping The TRT Bandwagon” - FDA Insider REVEALS Agencies SECRET War On Testosterone

Key Concepts

• Steroids: Naturally occurring chemicals in the body, with exogenous steroids having potential short-term benefits but long-term harms when used for cosmetic purposes.
• Testosterone Replacement Therapy (TRT): A medical treatment for men with low testosterone levels, aiming to restore physiological levels and potentially offer health benefits.
• Hormone Replacement Therapy (HRT) for Women: Treatment for post-menopausal women to replace declining estrogen and progesterone levels, addressing symptoms and offering long-term health benefits.
• Muscle Mass: Identified as the number one predictor of longevity.
• Menopause: The natural cessation of menstruation in women, typically between ages 45-55, leading to estrogen decline and associated symptoms.
• Estrogen: A key hormone in women that maintains blood vessel health and has protective effects against various health issues.
• Dogma in Medicine: The adherence to established beliefs or doctrines, sometimes leading to misinterpretations and harmful medical practices, as seen with HRT for women.
• FDA Forum on TRT: An upcoming event to address the underattention and stigma surrounding testosterone replacement therapy in men's health.

Steroids and Testosterone Replacement Therapy (TRT)

The discussion begins with a personal anecdote about aspiring to be a bodybuilder and the historical perception of steroids. In the past, information about steroids was often found in publications like "The Steroid Bible," which predominantly portrayed testosterone negatively. There was a significant stigma around steroid use, with individuals often denying it. However, this perception has evolved.

Evolution of Steroid Perception:

• Past: Steroids were viewed solely as a means to "get buffed up," with an emphasis on short-term aesthetic benefits and an understanding of long-term harms. Testosterone was particularly demonized, leading to its classification as a controlled substance after its use as a performance enhancer in the 1980s Olympics.
• Present: There's a growing recognition of the potential therapeutic role of exogenous testosterone, particularly in the context of Testosterone Replacement Therapy (TRT) for men experiencing low testosterone production.

TRT in Men's Health:

• Medical Rationale: The medical community is increasingly acknowledging that TRT can provide benefits similar to naturally high testosterone levels, including maintaining muscle mass.
• Muscle Mass and Longevity: A significant point raised is that muscle mass is the number one predictor of longevity. While this may be linked to activity levels, measurable muscle mass (e.g., via CAT scan) is a strong indicator.
• FDA Initiative: The Food and Drug Administration (FDA) is holding a forum on December 13th to address TRT in men's health, recognizing that it has not received adequate attention and is subject to stigma.
• Potential Benefits: Low-dose testosterone, when medically indicated, may offer long-term health benefits.
• Expert Involvement: Brian Christine, a men's health expert, will lead the FDA forum.

Hormone Replacement Therapy (HRT) for Post-Menopausal Women

The conversation then shifts to Hormone Replacement Therapy (HRT) for women, which is described as a "biggest screw up of modern medicine" due to its demonization.

The Misinformation Campaign:

• Origin: The negative perception of HRT for women largely stems from a decree made by a figure at the NIH in 2002, based on a misinterpreted study.
• Study Misinterpretation: The study, when analyzed closely, did not show a statistically significant increase in breast cancer. However, the lead investigator claimed it did, leading to widespread fear among women.
• Lack of Subsequent Evidence: No subsequent studies have confirmed an increased risk of breast cancer mortality from HRT.
• Consequences: Women were scared away from a treatment that could be life-changing, life-saving, and life-extending.

Benefits of HRT for Women:

• Symptom Alleviation: HRT effectively alleviates short-term menopausal symptoms, which can last for an average of eight years, contrary to the outdated medical school teaching that symptoms were mild and short-lived. These symptoms include hot flashes, night sweats, mood swings, and weight gain.
• Improved Quality of Life: HRT can significantly improve a woman's quality of life, even saving marriages by addressing issues like painful intercourse due to vaginal dryness.
• Profound Long-Term Health Benefits:
  • Cardiovascular Health: Reduces the risk of fatal heart attacks by 25-50%, a leading cause of death in women. This is supported by top cardiology journal studies.
  • Osteoporosis Prevention: Approximately 90% effective in reducing osteoporosis and the risk of bone fractures later in life. Weak bones due to estrogen decline are a root cause of fractures, which can lead to disability and death.
  • Cognitive Decline: Reduces cognitive decline in later life.

Timing and Dosing of HRT:

• Critical Window: The benefits of HRT are most profound when started within 10 years of menopause or before the age of 60. This is because estrogen is crucial for maintaining healthy blood vessel walls.
• Risk-Benefit Inversion: Starting HRT more than 10 years after menopause or after age 60 is generally not recommended as the risk-benefit ratio can invert.
• Underlying Issue: The decline in estrogen levels at menopause is the root cause of many long-term health issues for women.

The "Dogma" and its Impact:

• The NIH decree in 2002, driven by dogma and the ego of certain individuals rather than objective scientific consensus, created a widespread fear of HRT.
• The lead investigator of the pivotal study had a pre-existing agenda to "stop the HRT bandwagon."
• The study's findings were manipulated and released to the media without the full data, creating a false narrative that linked HRT to breast cancer.

Conclusion

The discussion highlights a significant shift in understanding regarding both testosterone replacement therapy for men and hormone replacement therapy for women. Historically demonized and stigmatized, these therapies are now being re-evaluated for their potential to improve health outcomes and longevity. The key takeaway is that medical dogma and misinterpretations of data can have profound negative consequences on public health, and a more nuanced, evidence-based approach is crucial for optimizing patient care. The upcoming FDA forum on TRT signifies a move towards addressing these underappreciated areas of men's health. Similarly, the re-evaluation of HRT for women underscores the importance of accurate scientific communication and the potential for life-altering benefits when treatments are not unfairly demonized.